Holland Capital Invests in Curess
Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.
Systemic Family Support
Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.
Strategic Parntership
With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.
Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”
Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”
About Curess
With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.
Autheos receives substantial investment for innovative video syndication network
American VC-veteran Guy Bradley and Holland Venture invest in Amsterdam-based startup AutheosAmsterdam, 27 june 2016 – Investment firm Holland Venture and Guy Bradley co-invest in Autheos. Autheos offers a many-to-many syndication network for brand and product videos....
Holland Venture and BOM invest in CytoSMART: digital microscopic imaging in the cloud
Amsterdam/Tilburg, 13 June 2016 - Private equity firm Holland Venture and the Brabant Development Agency (BOM) are together investing in CytoSMART Technologies. Founded in 2012 under the name CytoMATE, CytoSMART is a spin-off of Eindhoven University of Technology...
Humeca officially launches sister company Humeca, Inc. in the USA
Amsterdam, 12 februari 2016 - The launch follows a steady growth in demand and supply of their products worldwide and enables Humeca to expand their distribution network in the United States. The skin grafting products are life-saving for the treatment of burn...
Holland Venture provides substantial investment to marketing technology company Relay42
Amsterdam, December 8th 2015 – Holland Venture and a former Board Executive of Booking.com have invested several millions of euros in the Dutch data management specialist Relay42. Marketers use Relay42’s innovative data management platform to coordinate the customer...
Roelant Prins (Adyen) shares his experiences at Holland Venture’s first Growth Session
Holland Venture’s first Growth Session, with guest speaker Roelant Prins – CCO of Adyen – was a great success. In an interactive session with entrepreneurs and the Holland Venture team participating, Roelant shared his experiences in managing a fast growing...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl